Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 147,829 |
|
|||||
| News | - | ||||||
| Day High | 0.51 | Low High |
|||||
| Day Low | 0.472 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cadrenal Therapeutics Inc | CVKD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.025 | -5.00% | 0.475 | 17:20:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4965 | 0.472 | 0.51 | 0.48 | 0.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 439 | 147,829 | $ 0.493903 | $ 73,013 | - | 0.36 - 3.14 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:14:46 | formt | 190 | $ 0.475 | USD |
Cadrenal Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.68M | 16.01M | - | 0 | -8.36M | -0.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cadrenal Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVKD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.46 | 0.521 | 0.4311 | 0.4834396 | 161,364 | 0.015 | 3.26% |
| 1 Month | 0.5726 | 0.5796 | 0.36 | 0.4215447 | 494,750 | -0.0976 | -17.05% |
| 3 Months | 0.98 | 1.011 | 0.36 | 0.5011842 | 252,264 | -0.505 | -51.53% |
| 6 Months | 0.4494 | 2.17 | 0.36 | 0.8703557 | 282,503 | 0.0256 | 5.70% |
| 1 Year | 1.37 | 3.14 | 0.36 | 1.28 | 251,832 | -0.895 | -65.33% |
| 3 Years | 5.71 | 6.75 | 0.36 | 1.65 | 241,713 | -5.24 | -91.68% |
| 5 Years | 5.71 | 6.75 | 0.36 | 1.65 | 241,713 | -5.24 | -91.68% |
Cadrenal Therapeutics Description
| Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib. |
